Lydon Nicholas 4
4 · Blueprint Medicines Corp · Filed Jun 26, 2020
Insider Transaction Report
Form 4
Lydon Nicholas
Director
Transactions
- Award
Common Stock
2020-06-24+2,250→ 77,872 total - Award
Stock Option (Right to Buy)
2020-06-24+4,500→ 4,500 totalExercise: $76.24Exp: 2030-06-24→ Common Stock (4,500 underlying)
Footnotes (2)
- [F1]The reported transaction involved the Reporting Person's receipt of a grant of restricted stock units. The restricted stock units vest with respect to 100% of the shares underlying the restricted stock units on the earlier of (i) the next annual meeting of the Issuer's stockholders and (ii) June 24, 2021. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.
- [F2]This option vests with respect to 100% of the shares underlying the option on the earlier of (i) the next annual meeting of the Issuer's stockholders and (ii) June 24, 2021.